As of Nov 19, 2026, 1 of 2 active firms rate GEVO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
GEVO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.01
Range $-0.01 – $-0.01 · 1 analysts · -90% YoY
Next period, 1 analysts expect Gevo Inc to earn $-0.01 a share (range $-0.01 – $-0.01), versus $-0.09 a year earlier. Full-year consensus is $-0.69, growing to $-0.01 the year after.
REVENUE · NEXT QUARTER
$48.5M
Range $43.9M – $54.3M · 1 analysts · +13% YoY
Revenue is expected to reach $48.5M (range $43.9M – $54.3M), +13.0% year-over-year. Full-year consensus is $237.5M, rising to $213.3M next year.
Top analysts covering Gevo Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GEVO.
#1
Manav Gupta
UBS · Rank #236
Neutral
$2.00+17.3% to target
Overall win rate
41%
+ Follow
#2
Amit Dayal
HC Wainwright & Co. · Rank #519
Buy
$14.00+721.1% to target
Overall win rate
26%
+ Follow
#3
JG
Jeff Grampp
Northland Capital Markets
Buy
$3.50+105.3% to target
Coverage
—
+ Follow
GEVO stock forecast FAQ
What is GEVO's average 12-month price target?+
The 2 active firms with a live target average $2.75 for Gevo Inc over the next 12 months, ranging from a $3.50 high to a $2.00 low, as of Nov 19, 2026.
Is GEVO stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for GEVO?+
The Street-high target is $3.50 (Northland Capital Markets), and the Street-low is $2.00 (UBS). The average of all 2 active-firm targets is $2.75.
How many active Wall Street firms cover GEVO?+
2 active firms have a recognized rating on Gevo Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering GEVO?+
Among analysts who currently cover GEVO, Manav Gupta of UBS has the strongest overall Quantellect track record (Rank #236). Their current call is Neutral with a $2.00 target.
What is Gevo Inc's projected EPS for next quarter?+
The consensus estimate is $-0.01 per share (range $-0.01 – $-0.01) across 1 analysts. Full-year EPS is projected at $-0.69, rising to $-0.01 the following year.
How much revenue is Gevo Inc expected to report next quarter?+
Consensus revenue is $48.5M (range $43.9M – $54.3M). Full-year revenue is projected at $237.5M, growing to $213.3M next year.
Have analysts been upgrading or downgrading GEVO lately?+
As of Nov 19, 2026, 1 of 2 active firms rate GEVO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GEVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.